Dr. Thomas Helleday, Karolinska Institutet (IMAGE)
Caption
Dr. Thomas Helleday of Karolinska Institutet and his colleagues have identified a new way of treating cancer by inhibiting the enzyme MTH1, which cancer cells require for survival.
Credit
Ulf Sirborn
Usage Restrictions
This image may only be resproduced/published in connection to media reports about Thomas Helleday and his work at Karolinska Institutet and/or SciLifeLab.
License
Licensed content